Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
about
The Role of Gut Microbiome and Associated Metabolome in the Regulation of Neuroinflammation in Multiple Sclerosis and Its Implications in Attenuating Chronic Inflammation in Other Inflammatory and Autoimmune Disorders.Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?Probiotic Species in the Modulation of Gut Microbiota: An Overview.Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiomeEmerging Role of Diet and Microbiota Interactions in NeuroinflammationNutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
P2860
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Oral Administration of the Pro ...... Intestinal Barrier Dysfunction
@en
type
label
Oral Administration of the Pro ...... Intestinal Barrier Dysfunction
@en
prefLabel
Oral Administration of the Pro ...... Intestinal Barrier Dysfunction
@en
P2093
P2860
P50
P356
P1476
Oral Administration of the Pro ...... Intestinal Barrier Dysfunction
@en
P2093
Abdelhadi Saoudi
Mehdi Benamar
Michele Boury
Sahar Kassem
Thomas Secher
P2860
P356
10.3389/FIMMU.2017.01096
P577
2017-09-14T00:00:00Z